-
1
-
-
0001533777
-
Feverfew faces the future
-
Berry M.I. Feverfew faces the future. J Pharm Pharmacol. 232:1984;611-614.
-
(1984)
J Pharm Pharmacol
, vol.232
, pp. 611-614
-
-
Berry, M.I.1
-
2
-
-
0031007261
-
Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.): Assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in vitro
-
Brown A.M., Edwards C.M., Davey M.R., Power J.B., Lowe K.C. Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.) Assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in vitro . J Pharm Pharmacol. 49:1997;558-561.
-
(1997)
J Pharm Pharmacol
, vol.49
, pp. 558-561
-
-
Brown, A.M.1
Edwards, C.M.2
Davey, M.R.3
Power, J.B.4
Lowe, K.C.5
-
3
-
-
0030600363
-
Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases
-
Hwang D., Fischer N.H., Jang B.C., Tak H., Kim J.K., Lee W. Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases. Biochem Biophys Res Commun. 226:1996;810-818.
-
(1996)
Biochem Biophys Res Commun
, vol.226
, pp. 810-818
-
-
Hwang, D.1
Fischer, N.H.2
Jang, B.C.3
Tak, H.4
Kim, J.K.5
Lee, W.6
-
4
-
-
0001653365
-
Sesquiterpene lactones and other constituents from Tanacetum parthenium
-
Bohlmann F., Zdero C. Sesquiterpene lactones and other constituents from Tanacetum parthenium. Phytochemistry. 21:1982;2543-2549.
-
(1982)
Phytochemistry
, vol.21
, pp. 2543-2549
-
-
Bohlmann, F.1
Zdero, C.2
-
5
-
-
0031002421
-
Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages
-
Xia Y., Zweier J.L. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA. 94:1997;6954-6958.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 6954-6958
-
-
Xia, Y.1
Zweier, J.L.2
-
6
-
-
0028329887
-
Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis
-
Nunokawa Y., Ishida N., Tanaka S. Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem Biophys Res Commun. 200:1994;802-807.
-
(1994)
Biochem Biophys Res Commun
, vol.200
, pp. 802-807
-
-
Nunokawa, Y.1
Ishida, N.2
Tanaka, S.3
-
7
-
-
0024551872
-
The mechanism of skin tumor promotion caused by phorbol esters: Possible involvement of arachidonic acid cascade/lipoxygenase, protein kinase C and calcium/calmodulin systems
-
Nakadate T. The mechanism of skin tumor promotion caused by phorbol esters Possible involvement of arachidonic acid cascade/lipoxygenase, protein kinase C and calcium/calmodulin systems . Jpn J Pharmacol. 49:1989;1-9.
-
(1989)
Jpn J Pharmacol
, vol.49
, pp. 1-9
-
-
Nakadate, T.1
-
8
-
-
0024233953
-
Structural and functional studies of protein kinase C
-
Housey G.M., Johnson M.D., Hsiao W.L., O'Brian C.A., Weinstein I.B. Structural and functional studies of protein kinase C. Adv Exp Med Biol. 234:1988;127-140.
-
(1988)
Adv Exp Med Biol
, vol.234
, pp. 127-140
-
-
Housey, G.M.1
Johnson, M.D.2
Hsiao, W.L.3
O'Brian, C.A.4
Weinstein, I.B.5
-
9
-
-
0033053182
-
Phorbol ester-induced mononuclear cell differentiation is blocked by the mitogen-activated protein kinase kinase (MEK) inhibitor PD98059
-
He H., Wang X., Gorospe M., Holbrook N.J., Trush M.A. Phorbol ester-induced mononuclear cell differentiation is blocked by the mitogen-activated protein kinase kinase (MEK) inhibitor PD98059. Cell Growth Differ. 10:1999;307-315.
-
(1999)
Cell Growth Differ
, vol.10
, pp. 307-315
-
-
He, H.1
Wang, X.2
Gorospe, M.3
Holbrook, N.J.4
Trush, M.A.5
-
10
-
-
0023221336
-
Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups
-
Heptinstall S., Groenewegen W.A., Spangenberg P., Loesche W. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. J Pharm Pharmacol. 39:1987;459-465.
-
(1987)
J Pharm Pharmacol
, vol.39
, pp. 459-465
-
-
Heptinstall, S.1
Groenewegen, W.A.2
Spangenberg, P.3
Loesche, W.4
-
11
-
-
0033610023
-
Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells
-
Wong H.R., Menendez I.Y. Sesquiterpene lactones inhibit inducible nitric oxide synthase gene expression in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun. 262:1999;375-380.
-
(1999)
Biochem Biophys Res Commun
, vol.262
, pp. 375-380
-
-
Wong, H.R.1
Menendez, I.Y.2
-
12
-
-
0031915368
-
Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α And IκB-β
-
Hehner S.P., Heinrich M., Bork P.M., Vogt M., Ratter F., Lehmann V., Schulze-Osthoff K., Droge W., Schmitz M.L. Sesquiterpene lactones specifically inhibit activation of NF-κB by preventing the degradation of IκB-α and IκB-β J Biol Chem. 273:1998;1288-1297.
-
(1998)
J Biol Chem
, vol.273
, pp. 1288-1297
-
-
Hehner, S.P.1
Heinrich, M.2
Bork, P.M.3
Vogt, M.4
Ratter, F.5
Lehmann, V.6
Schulze-Osthoff, K.7
Droge, W.8
Schmitz, M.L.9
-
13
-
-
0033571108
-
The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IκB kinase complex
-
Hehner S.P., Hofmann T.G., Droge W., Schmitz M.L. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IκB kinase complex. J Immunol. 163:1999;5617-5623.
-
(1999)
J Immunol
, vol.163
, pp. 5617-5623
-
-
Hehner, S.P.1
Hofmann, T.G.2
Droge, W.3
Schmitz, M.L.4
-
14
-
-
0028902123
-
Modulation of transcription factor NFκB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply
-
Mihm S., Galter D., Droge W. Modulation of transcription factor NFκB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. FASEB J. 9:1995;246-252.
-
(1995)
FASEB J
, vol.9
, pp. 246-252
-
-
Mihm, S.1
Galter, D.2
Droge, W.3
-
15
-
-
0032415840
-
Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease
-
Dijkstra G., Moshage H., van Dullemen H.M., de Jager-Krikken A., Tiebosch A.T., Kleibeuker J.H., Jansen P.L., van Goor H. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol. 186:1998;416-421.
-
(1998)
J Pathol
, vol.186
, pp. 416-421
-
-
Dijkstra, G.1
Moshage, H.2
Van Dullemen, H.M.3
De Jager-Krikken, A.4
Tiebosch, A.T.5
Kleibeuker, J.H.6
Jansen, P.L.7
Van Goor, H.8
-
16
-
-
0025189864
-
Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
-
Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite Implications for endothelial injury from nitric oxide and superoxide . Proc Natl Acad Sci USA. 87:1990;1620-1624.
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 1620-1624
-
-
Beckman, J.S.1
Beckman, T.W.2
Chen, J.3
Marshall, P.A.4
Freeman, B.A.5
-
17
-
-
0023918670
-
Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones
-
Hall I.H., Williams W.L. Jr, Grippo A.A., Lee K.H., Holbrook D.J., Chaney S.G. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia cells in culture by sesquiterpene lactones. Anticancer Res. 8:1988;33-42.
-
(1988)
Anticancer Res
, vol.8
, pp. 33-42
-
-
Hall, I.H.1
Williams W.L., Jr.2
Grippo, A.A.3
Lee, K.H.4
Holbrook, D.J.5
Chaney, S.G.6
-
18
-
-
0032990502
-
Low concentrations of the feverfew component parthenolide inhibit in vitro growth of tumor lines in a cytostatic fashion
-
Ross J.J., Arnason J.T., Birnboim H.C. Low concentrations of the feverfew component parthenolide inhibit in vitro growth of tumor lines in a cytostatic fashion. Planta Med. 65:1999;126-129.
-
(1999)
Planta Med
, vol.65
, pp. 126-129
-
-
Ross, J.J.1
Arnason, J.T.2
Birnboim, H.C.3
|